Search
Close this search box.

Bosnalijek CEO Accused of Causing Company Losses of 10.8 Million BAM

The Prosecutor’s Office of Bosnia and Herzegovina has accused the director of Bosnalijek, Nedim Uzunović, his associates, and family members of using the company’s funds to purchase shares, cars, and real estate in Croatia and Bosnia and Herzegovina.
Foto: Bosnalijek
Foto: Bosnalijek

Nedim Uzunović, the CEO and co-owner of Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina (BiH), has been accused of organizing a criminal group, abusing his position, money laundering, and entering into contracts detrimental to the company from 2005 to 2016.

In addition to Uzunović, the Prosecutor’s Office of BiH has charged ten individuals, including members of his family, and four companies from BiH and Croatia with the same offenses. According to the indictment, they collectively caused damages to Bosnalijek amounting to approximately 10.8 million BAM while gaining an illegal financial benefit of nearly ten million. With this money, among other things, they acquired shares and assets in BiH and Croatia.

The Prosecutor’s Office alleges that Nedim Uzunović, as the General Manager of Bosnalijek’s Moscow office and later, from 2005 to 2016, established offshore companies through intermediaries, to which he assigned fictitious marketing and other contracts with Bosnalijek. The money from these transactions landed in the private accounts of Uzunović and his associates and family members, which they legalized by purchasing Bosnalijek shares, real estate, vehicles, and other assets.

The prosecution will substantiate these claims with documents obtained from judicial institutions in Latvia, Cyprus, Croatia, Slovenia, and other countries, among other evidence. The indictment has been forwarded to the Court of Bosnia and Herzegovina for confirmation.

Russians Improperly Parked in Bosnalijek
Haden, a Luxembourg investment, arranged a buyout of Bosnalijek’s shares in violation of laws and Sarajevo stock exchange rules.

CIN has reported on Uzunović’s abuses multiple times over the past seven years. He misappropriated the company’s funds on two occasions: first as the General Manager of Bosnalijek’s Moscow office from 2005 to 2012 when the company was predominantly owned by the BiH Federation Government, and later as the CEO in Sarajevo in 2016 and 2017 when it was under the control of Russian investors concealed behind the Luxembourg-based offshore fund Haden.

The Cost of Pills for Bosnalijek
Two years after Russian investors took over Bosnalijek for 32 million KM their firm went bankrupt, defaulting on as much debt to the Sarajevo factory as they had put down for its acquisition.

Readers’ support helps CIN reveal corruption and organized crime.
Your donation supports investigative journalism as a public good.

Facebook
Twitter
LinkedIn
Email
WhatsApp
Print

Anonimna prijava

Svojim anonimnim prijavama doprinosite integritetu naše zajednice. Molimo vas da iskoristite ovu formu kako biste sigurno prijavili bilo kakvu sumnju u korupciju ili nezakonitu aktivnost koju primijetite. Vaša hrabrost ključna je za očuvanje naših vrijednosti i promicanje transparentnosti.